Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts guidance cnbc.com 4 points by TMWNN 16 hours ago
joezydeco 15 hours ago Press release omits the fact that NN forgot to renew the Canadian patent in 2019 and the drug goes generic north of the border in 2026.https://www.science.org/content/blog-post/novo-nordisk-s-can... TMWNN 15 hours ago Not a mistake. fox in the comments explains what Novo Nordisk was thinking at the time. The PMPRB he mentions is <https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Revie...>
TMWNN 15 hours ago Not a mistake. fox in the comments explains what Novo Nordisk was thinking at the time. The PMPRB he mentions is <https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Revie...>
TMWNN 16 hours ago Edited by me from "Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance"
Press release omits the fact that NN forgot to renew the Canadian patent in 2019 and the drug goes generic north of the border in 2026.
https://www.science.org/content/blog-post/novo-nordisk-s-can...
Not a mistake. fox in the comments explains what Novo Nordisk was thinking at the time. The PMPRB he mentions is <https://en.wikipedia.org/wiki/Patented_Medicine_Prices_Revie...>
Edited by me from "Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance"